You appear to be offline. Some data may be unavailable until your connection is restored.

BMY

Stock

Bristol-Myers Squibb Company

Create price alert

Description

Bristol‑Myers Squibb is a global biopharmaceutical company that discovers, develops, manufactures and markets prescription medicines, primarily in oncology, hematology, immunology, cardiovascular disease and neuroscience. It operates in the pharmaceutical sector as a research‑driven drug manufacturer, selling products such as Opdivo, Breyanzi, Revlimid (historically) and newer launches like Sotyktu and Camzyos. The firm has built a leading market position through a combination of internal R&D and strategic acquisitions, notably Celgene, MyoKardia and Mirati, giving it a deep pipeline of late‑stage candidates and a broad portfolio across multiple therapeutic areas.

Dividend

4.23%annual yield
quarterly payout
Ex-Dividend: Oct 2, 2026
Payment: Nov 2, 2026
Payout: $0.63/share
Dividend history
AmountEx-DatePayment Date
$0.63Oct 2, 2026Nov 2, 2026
$0.63Jul 2, 2026Aug 3, 2026
$0.63Apr 2, 2026May 1, 2026

Track every BMY dividend

Get reminders ahead of BMY's ex-dividend and payment dates, so you always know when distributions are coming. Pair them with price and earnings alerts to keep your full income picture in view.